Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5761 to 5775 of 7682 results

  1. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    Recommendation ID CG113/3 Question For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention

    Research recommendation
    Published
    9 June 2015

  2. Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the clinical effectiveness of low-dose aspirin compared with placebo for primary prevention of cardiovascular disease?

    Recommendation ID NG203/19 Question Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the

    Research recommendation
    Published
    30 September 2021

  3. Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical and cost effectiveness of thyroid peroxidase antibody testing?

    Recommendation ID NG230/06 Question Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical

    Research recommendation
    Published
    6 January 2023

  4. Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged skin, usually on the face) how effective is Mohs micrographic surgery, compared with excision with a 0.5 cm clinical margin, in preventing biopsy proven local recurrence at 5 years? This should be investigated in a randomised controlled trial. Secondary outcomes should include cosmetic and functional outcomes.

    Recommendation ID NG14/08 Question Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged

    Research recommendation
    Published
    4 August 2022

  5. For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter tricuspid valve annuloplasty is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG730/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter

    Research recommendation
    Published
    4 August 2022

  6. For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter tricuspid valve leaflet repair is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG731/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter

    Research recommendation
    Published
    5 August 2022

  7. Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom characteristics?

    Recommendation ID CG173/2 Question Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom

    Research recommendation
    Published
    26 October 2020

  8. NICE may update this guidance after 3 years or sooner if important new information becomes available, including evidence on: the epidemiology of CJD, including data on the prevalence of CJD and its infectivity in the UK population the transmission of CJD by surgical instruments, including cases of CJD in which surgery is a possible route of transmission the cost effectiveness of single-use instruments for use in interventional procedures on high-risk tissues commercially available decontmination methods that are safe and cost effective against prions the systems for, and cost effectiveness of, maintaining set integrity and traceability of instruments.

    Recommendation ID IPG666/1 Question NICE may update this guidance after 3 years or sooner if important new information becomes available

    Research recommendation
    Published
    10 February 2020

  9. When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    Recommendation ID NG19/2 Question When and with what criteria should people with diabetes be referred to the foot protection service or

    Research recommendation
    Published
    15 November 2019

  10. The evidence on the safety of reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia shows there are serious but well-recognised complications. The evidence on efficacy is limited in quantity and quality. Therefore, this procedure should not be used unless  special arrangements   are in place for clinical governance, consent, and audit or research.

    Recommendation ID IPG654/1 Question The evidence on the safety of reinforcement of a permanent stoma with a synthetic or biological mesh

    Research recommendation
    Published
    15 November 2019

  11. Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma filtering (pathways from case-finding to assessment in secondary ophthalmic care) for detecting glaucoma and glaucoma-related conditions (ocular hypertension and suspected glaucoma)?

    Recommendation ID NG81/5 Question Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma

    Research recommendation
    Published
    18 October 2018

  12. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    Recommendation ID CG61/3 Question Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS? Any explanatory

    Research recommendation
    Published
    9 June 2015

  13. Red blood cell transfusion thresholds for patients with chronic cardiovascular  disease:- What is the clinical and cost effectiveness of restrictive compared with liberal red blood cell thresholds and targets for patients with chronic cardiovascular disease?

    Recommendation ID NG24/1 Question Red blood cell transfusion thresholds for patients with chronic cardiovascular disease:- What is the

    Research recommendation
    Published
    11 December 2015

  14. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    Recommendation ID PH47/3 Question Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners

    Research recommendation
    Published
    9 June 2015

  15. Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners and funders.

    Recommendation ID PH47/1 Question Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners

    Research recommendation
    Published
    9 June 2015